DeepMed Research

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Phase 2

Conditions: Leukemia

Interventions: Drug: cyclophosphamide
Drug: cytarabine
Drug: daunorubicin hydrochloride
Drug: dexamethasone
Drug: doxorubicin hydrochloride
Drug: mercaptopurine
Drug: methotrexate
Drug: pegaspargase
Drug: thioguanine
Drug: vincristine sulfate
Radiation: radiation therapy

First Posted Date: 2007-11-15

Last Posted Date: 2021-08-18

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 318

Registration Number: NCT00558519

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: carboplatin
Drug: erlotinib hydrochloride
Drug: paclitaxel albumin-stabilized nanoparticle formulation
Radiation: radiation therapy

First Posted Date: 2007-11-04

Last Posted Date: 2018-01-31

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 78

Registration Number: NCT00553462

Locations: 🇺🇸
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States
🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
Heartland Regional Medical Center, Saint Joseph, Missouri, United States

and more 96 locations

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: everolimus
Drug: temozolomide
Radiation: radiation

First Posted Date: 2007-11-04

Last Posted Date: 2020-02-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 122

Registration Number: NCT00553150

Locations: 🇺🇸
Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

and more 173 locations

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: epratuzumab
Biological: rituximab

First Posted Date: 2007-11-04

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 60

Registration Number: NCT00553501

Locations: 🇺🇸
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
🇺🇸
University of Illinois Cancer Center, Chicago, Illinois, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States

and more 40 locations

Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: erlotinib hydrochloride
Biological: panitumumab
Drug: gemcitabine hydrochloride

First Posted Date: 2007-10-30

Last Posted Date: 2017-04-05

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 104

Registration Number: NCT00550836

Locations: 🇺🇸
Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States
🇺🇸
Northern Montana Hospital, Havre, Montana, United States
🇺🇸
Big Sky Oncology, Great Falls, Montana, United States

and more 254 locations

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

Phase 3

Terminated

Conditions: Melanoma (Skin)
Kidney Cancer
Pain
Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Procedure: cryosurgery
Radiation: radiation therapy

First Posted Date: 2007-10-08

Last Posted Date: 2018-11-21

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 3

Registration Number: NCT00540969

Locations: 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

and more 4 locations

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Phase 2

Completed

Conditions: Melanoma (Skin)

Interventions: Drug: everolimus
Drug: temozolomide

First Posted Date: 2007-08-27

Last Posted Date: 2017-08-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 49

Registration Number: NCT00521001

Locations: 🇺🇸
Meeker County Memorial Hospital, Litchfield, Minnesota, United States
🇺🇸
St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
🇺🇸
Memorial Hospital, Carthage, Illinois, United States

and more 192 locations

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Genetic: polymorphism analysis
Other: high performance liquid chromatography
Other: laboratory biomarker analysis
Procedure: radiomammography

First Posted Date: 2007-08-15

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 140

Registration Number: NCT00516698

Locations: 🇺🇸
Rush-Copley Cancer Care Center, Aurora, Illinois, United States
🇺🇸
Mason District Hospital, Havana, Illinois, United States
🇺🇸
Graham Hospital, Canton, Illinois, United States

and more 174 locations

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Phase 3

Completed

Conditions: Myelodysplastic/Myeloproliferative Neoplasms
Lymphoma
Lymphoproliferative Disorder
Chronic Myeloproliferative Disorders
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Leukemia
Pain
Unspecified Adult Solid Tumor, Protocol Specific
Neurotoxicity

Interventions: Drug: baclofen/amitriptyline/ketamine gel
Other: placebo

First Posted Date: 2007-08-15

Last Posted Date: 2017-08-24

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 208

Registration Number: NCT00516503

Locations: 🇺🇸
Graham Hospital, Canton, Illinois, United States
🇺🇸
Galesburg Cottage Hospital, Galesburg, Illinois, United States
🇺🇸
Mercy Medical Center - Sioux City, Sioux City, Iowa, United States

and more 159 locations

Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: galiximab

First Posted Date: 2007-08-15

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 30

Registration Number: NCT00516217

Locations: 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Galesburg Clinic, PC, Galesburg, Illinois, United States
🇺🇸
Perry Memorial Hospital, Princeton, Illinois, United States

and more 53 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy